Pfizer preps animal health IPO; Value-based pricing stirs anxiety among drug companies;

 @FierceBiotech: Catalent continues restructuring efforts as it completes work on NC fill-finish plant. News | Follow @FierceBiotech

 @RyanMFierce: My post about how Lilly leads docs to cancer drug trials with iPad app. Article | Follow @RyanMFierce

> Pfizer ($PFE) is prepping registration documents for an animal-health IPO. The company would offer a minority stake in the unit, dubbed Zoetis, as a step toward spinning off the unit completely. It's the latest update on Pfizer's efforts to refocus on its "innovative core." Report

> The U.K.'s move to a "value-based" pricing strategy for therapeutics is causing some deep anxiety among drug companies, which believe it could seriously undermine drug innovation in the country. Story

> The Ontario Institute for Cancer Research is providing $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov Pharma, Inc. The drug, called FV-162, is a small molecule proteasome inhibitor for multiple myeloma and some forms of Non-Hodgkin lymphoma. Release

Pharma News

 @FiercePharma: Pfizer plans IPO for minority stake in animal-health unit--dubbed "Zoetis"--on its way to total spinoff. Report | Follow @FiercePharma

> Pharma feeds multiply on Twitter. Story

> Lilly chief skeptical of buyouts--and not just megadeals. Article

> Will Horizant's new use soothe tempers at XenoPort, GSK? More

> Novartis yanks mispackaged birth-control pills. News

Medical Devices News

 @FierceMedDev: Only a few weeks left to submit your nominations for the 15 fiercest private device developers. Survey | Follow @FierceMedDev

> Device tax repeal up for House vote today as White House threatens veto. Item

> Mindray snaps up Chinese orthopedics maker for $35.5M. Story

> Report: Panasonic to become major Olympus shareholder with $635M investment. More

CRO News

 @NesaNFierce: Catalent's renovated fill-finish plant in NC is more in-tune with the company's renewed business focus. Article | Follow @NesaNFierce

> Siegfried buys Allied Medical Products for $58M. News

> Medtox's toxicology offerings contribute to LabCorp acquisition, as contract manufacturing shrinks. More

> WuXi PharmaTech speaks out on compound theft by former employee. Article

> Kansas City CROs form alliance to attract outsourcing work to region. Item

Pharma Manufacturing News

> FDA commish suggests drugmakers get on board with track and trace. More

> Sandoz recalls Introvale contraceptives. News

> Indian API maker looks to Asia for cheap energy. Report

Vaccines News

> NewLink Genetics takes the stage at ASCO. Story

> Vax, hormone combo could up efficacy in prostate cancer. Article

> Mapping the way to a Candida vaccine. Item

> Affiris' Parkinson's therapeutic vax starts clinical trials. More

And Finally... Researchers at Mount Sinai say they have been working on a new therapy that has the potential to treat multiple tumors. And they say it could offer a whole new approach to cancer drug discovery. Release